Is MXC aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities?
No. MXC is not aware of any information concerning the Company that has not been announced to the market. The Company has recently released a number of material announcements, specifically in relation to MXC’s Medicinal Cannabis based IMP, CannEpilTM, now being available for supply in Australia under the Authorised Prescriber Scheme, and the strategic disposal of its MGC Derma business to a Canadian cannabis company. MXC confirms it would advise the market immediately if there are any material changes to the terms as previously announced.
MXC Price at posting:
7.9¢ Sentiment: Buy Disclosure: Held
